Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of molecular medicine

• Publication date

  2009-08-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00109-009-0512-xPMID 19690824
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cannabidiol, extracted from Cannabis sativa, selectively inhibits inflammatory hypermotility in mice

  2008cited by this paper
• The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarin

  2008cited by this paper
• Targeting the endocannabinoid system: to enhance or reduce?

  2008cited by this paper
• Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects

  2008influential reference
• Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation

  2008cited by this paper
• The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.

  2008cited by this paper
• Treatment of inflammatory bowel disease: a review of medical therapy.

  2008cited by this paper
• Effect of cannabidiol on sepsis‐induced motility disturbances in mice: involvement of CB1 receptors and fatty acid amide hydrolase

  2008cited by this paper
• The role of endocannabinoids in the regulation of gastric emptying: alterations in mice fed a high‐fat diet

  2008cited by this paper
• 5‐Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non‐psychoactive cannabinoid

  2008cited by this paper
• Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors

  2008cited by this paper
• Targeting the endocannabinoid system: to enhance or reduce?

  2008cited by this paper
• Unravelling the pathogenesis of inflammatory bowel disease

  2007cited by this paper
• Cannabidiol in vivo blunts β‐amyloid induced neuroinflammation by suppressing IL‐1β and iNOS expression

  2007cited by this paper
• Influence of simultaneous inhibition of cyclooxygenase-2 and inducible nitric oxide synthase in experimental colitis in rats

  2007cited by this paper
• Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression.

  2007cited by this paper
• Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption.

  2007cited by this paper
• The 10 remaining mysteries of inflammatory bowel disease

  2007cited by this paper
• Meta‐analysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differences

  2007cited by this paper
• Increased endocannabinoid levels reduce the development of precancerous lesions in the mouse colon

  2007cited by this paper
• Cannabidiol – Recent Advances

  2007cited by this paper
• The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain.

  2007cited by this paper
• The marijuana component cannabidiol inhibits beta-amyloid-induced tau protein hyperphosphorylation through Wnt/beta-catenin pathway rescue in PC12 cells.

  2006cited by this paper
• Endocannabinoid overactivity and intestinal inflammation

  2006cited by this paper
• The marijuana component cannabidiol inhibits β-amyloid-induced tau protein hyperphosphorylation through Wnt/β-catenin pathway rescue in PC12 cells

  2006cited by this paper
• Experimental colitis: decreased Octn2 and Atb0+ expression in rat colonocytes induces carnitine depletion that is reversible by carnitine‐loaded liposomes

  2006cited by this paper
• Agonists of cannabinoid receptor 1 and 2 inhibit experimental colitis induced by oil of mustard and by dextran sulfate sodium.

  2006cited by this paper
• Up‐regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation

  2006influential reference
• Effects of Uptake of Flavonoids on Oxidative Stress Induced by Hydrogen Peroxide in Human Intestinal Caco-2 Cells

  2006cited by this paper
• Antitumor Activity of Plant Cannabinoids with Emphasis on the Effect of Cannabidiol on Human Breast Carcinoma

  2006cited by this paper
• American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease.

  2006cited by this paper
• COX-2: A Pivotal Enzyme in Mucosal Protection and Resolution of Inflammation

  2006cited by this paper
• Fatty acid amide hydrolase controls mouse intestinal motility in vivo.

  2005cited by this paper
• Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes.

  2005cited by this paper
• The endogenous cannabinoid system protects against colonic inflammation.

  2004influential reference
• Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle

  2004cited by this paper
• Oxidative stress as a pathogenic factor in inflammatory bowel disease — radicals or ridiculous?

  2002cited by this paper
• Interleukin-1beta converting enzyme (caspase-1) in intestinal inflammation.

  2002cited by this paper
• Combining T cells and IL-10: a new therapy for Crohn's disease?

  2002cited by this paper
• Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide

  2001cited by this paper
• Interleukin 10 gene transfer prevents experimental colitis in rats

  2000cited by this paper
• Intestinal anti‐inflammatory activity of UR‐12746, a novel 5‐ASA conjugate, on acute and chronic experimental colitis in the rat

  2000cited by this paper
• From gan-zi-gun-nu to anandamide and 2-arachidonoylglycerol: the ongoing story of cannabis.

  1999cited by this paper
• Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease.

  1998cited by this paper
• Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants.

  1998cited by this paper
• Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2.

  1996cited by this paper
• Recombinant interleukin-1 receptor antagonist blocks the proinflammatory activity of endogenous interleukin-1 in rabbit immune colitis.

  1992cited by this paper
• Tumor-dependent increased plasma nitrate concentrations as an indication of the antitumor effect of flavone-8-acetic acid and analogues in mice.

  1991cited by this paper
• Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal.

  1990cited by this paper
• Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

  1983cited by this paper
• Chronic administration of cannabidiol to healthy volunteers and epileptic patients.

  1980cited by this paper

• Cannabidiol mitigates high-fat-diet-induced early-stage inflammation in two adipose tissue fat depots of Wistar rats

  2026cites this paper
• Post-weaning exposure to cannabidiol disrupts testicular cytoarchitecture and sperm quality in mice.

  2025cites this paper
• Combination of CBD with minor cannabinoid CBDV suppresses CXCR4 via CB2 receptor and alleviates colitis in mice.

  2025cites this paper
• Barrier-Strengthening Effects of Cannabidiol on Porcine Peyer’s Patches

  2025cites this paper
• A systematic review on the role of gut microbiome in inflammatory bowel disease: Spotlight on virome and plant metabolites.

  2025cites this paper
• The effect of cannabis-derived terpenes on alveolar macrophage function

  2025cites this paper
• Unveiling Neurological Benefits: A Review of Hemp Leaf, Flower, Seed Oil Extract, and Their Phytochemical Properties in Neurological Disorders

  2025cites this paper
• The Potential of Cannabis in Managing Inflammatory Bowel Disease and Its Future Perspective

  2024cites this paper
• The Modulatory Effects and Therapeutic Potential of Cannabidiol in the Gut

  2024cites this paper
• Exploring the Potential of Synthetic Cannabinoids: Modulation of Biological Activity of Normal and Cancerous Human Colon Epithelial Cells

  2024cites this paper
• The immunomodulatory effects of cannabidiol on Hsp70-activated NK cells and tumor target cells.

  2024cites this paper
• Selected phytocannabinoids inhibit SN-38- and cytokine-evoked increases in epithelial permeability and improve intestinal barrier function in vitro.

  2024cites this paper
• Emerging Natural Therapies for the Treatment of Inflammatory Bowel Disease.

  2024cites this paper
• Influence of short-term chronic oral cannabidiol application on muscle recovery and performance after an intensive training protocol - a randomized double-blind crossover study

  2024cites this paper
• Possible Role of Cannabis in the Management of Neuroinflammation in Patients with Post-COVID Condition

  2024cites this paper
• Dietary Cannabidiol Activates PKA/AMPK Signaling and Attenuates Chronic Inflammation and Leaky Gut in DSS-Induced Colitis Mice.

  2024cites this paper
• The NLRP3 inflammasome: a vital player in inflammation and mediating the anti-inflammatory effect of CBD

  2024cites this paper
• An Overview of Cannabidiol as a Multifunctional Drug: Pharmacokinetics and Cellular Effects

  2024cites this paper
• Effect of cannabinoids in mild-to-moderate cases of Crohn’s disease as compared to placebo: a systematic review and meta-analysis of randomised controlled trials

  2024cites this paper
• Cannabis sativa alleviates experimentally acetic acid- induced ulcerative colitis in rats: targeting CB1/SIRT/MAPK signaling pathways

  2024cites this paper
• Cannabidiol Enhances Mitochondrial Metabolism and Antioxidant Defenses in Human Intestinal Epithelial Caco-2 Cells

  2024cites this paper
• Cannabidiol and Intestinal Motility: a Systematic Review

  2023cites this paper
• Cannabidiol improves memory and decreases IL-1β serum levels in rats with lipopolysaccharide-induced inflammation.

  2023cites this paper
• Advances in the Treatment of Gingival Tissue Wound Healing with Plant Extracts

  2023cites this paper
• Cannabinoids in Periodontology: Where Are We Now?

  2023cites this paper
• Cannabidiol protects the liver from α-Amanitin-induced apoptosis and oxidative stress through the regulation of Nrf2.

  2023cites this paper
• Cannabis and Endometriosis: The Roles of the Gut Microbiota and the Endocannabinoid System

  2023cites this paper
• Cannabidiol - Help and hype in targeting mucosal diseases.

  2023cites this paper
• Antihypertensive effects of CBD are mediated by altered inflammatory response: A sub-study of the HYPER-H21-4 trial

  2023cites this paper
• Non-Intoxicating Cannabinoids in Visceral Pain

  2023cites this paper
• Polycaprolactone microparticles for the subcutaneous administration of cannabidiol: in vitro and in vivo release

  2023cites this paper
• The Potential of Cannabidiol for Acute Respiratory Distress Syndrome in COVID-19.

  2023cites this paper
• Effects of Cannabidiol in Inflammation: A Review of Pre-clinical and Clinical Findings.

  2023cites this paper
• Cannabidiol attenuates inflammatory impairment of intestinal cells expanding biomaterial-based therapeutic approaches

  2023cites this paper
• Cannabis Improves Clinical Outcomes and Quality of Life in Patients With Chronic Pouchitis

  2023cites this paper
• Altered endocannabinoidome bioactive lipid levels accompany reduced DNBS-induced colonic inflammation in germ-free mice

  2023cites this paper
• Cannabidiol as a potential novel treatment for endometriosis by its anti-inflammatory, antioxidative and antiangiogenic effects in an experimental rat model.

  2023cites this paper
• Beyond Pain Relief: A Review on Cannabidiol Potential in Medical Therapies

  2023cites this paper
• Cannabidiol regulates apoptosis and autophagy in inflammation and cancer: A review

  2023cites this paper
• Cannabidiol’s Multifactorial Mechanisms Has Therapeutic Potential for Aneurysmal Subarachnoid Hemorrhage: a Review

  2022cites this paper
• Cannabidiol-Treated Ovariectomized Mice Show Improved Glucose, Energy, and Bone Metabolism With a Bloom in Lactobacillus

  2022cites this paper
• Cannabidiol improves thyroid function via modulating vitamin D3 receptor in vitamin D3 deficiency diet-induced rat model

  2022cites this paper
• Acute Supplementation with Cannabidiol Does Not Attenuate Inflammation or Improve Measures of Performance following Strenuous Exercise

  2022cites this paper
• Involvement of the cannabinoid system in chronic inflammatory intestinal diseases: opportunities for new therapies

  2022influential citation
• Anti-inflammation and gingival wound healing activities of Cannabis sativa L. subsp. sativa (hemp) extract and cannabidiol: An in vitro study.

  2022cites this paper
• Cannabidiol on the Path from the Lab to the Cancer Patient: Opportunities and Challenges

  2022cites this paper
• Natural compounds as safe therapeutic options for ulcerative colitis

  2022cites this paper
• The NLRP3 Inflammasome in Stress Response: Another Target for the Promiscuous Cannabidiol

  2022cites this paper
• “The Two Sides of the Same Coin”—Medical Cannabis, Cannabinoids and Immunity: Pros and Cons Explained

  2022cites this paper
• Cannabinoids as Immune System Modulators: Cannabidiol Potential Therapeutic Approaches and Limitations

  2022cites this paper
• Disorders of cancer metabolism: The therapeutic potential of cannabinoids.

  2022cites this paper
• The gut microbiota in neurodegenerative diseases: revisiting possible therapeutic targets for cannabidiol

  2022cites this paper
• The Journal Therapeutics (JPET) Cannabidiol Enhances Intestinal CB2 Receptor Expression and Activation Increasing Regulatory T Cells and Reduces Murine Acute Graft-Versus-Host Disease without Interfering with The Graft-Versus-Leukemia Response

  2021cites this paper
• Immunomodulation by cannabinoids: Current uses, mechanisms, and identification of data gaps to be addressed for additional therapeutic application.

  2021cites this paper
• Inflammatory Bowel Disease and Cannabis: A Practical Approach for Clinicians

  2021cites this paper
• The anti-inflammatory effects of cannabidiol and cannabigerol alone, and in combination.

  2021cites this paper
• Cannabinoids and Inflammations of the Gut-Lung-Skin Barrier

  2021cites this paper
• The Effects of Cannabinoids on Pro- and Anti-Inflammatory Cytokines: A Systematic Review of In Vivo Studies

  2021influential citation
• Cannabinoids as Key Regulators of Inflammasome Signaling: A Current Perspective

  2021cites this paper
• Cannabidiol Enhances Intestinal Cannabinoid Receptor Type 2 Receptor Expression and Activation Increasing Regulatory T Cells and Reduces Murine Acute Graft-versus-Host Disease without Interfering with the Graft-versus-Leukemia Response

  2021cites this paper
• Cannabidiol Isolated From Cannabis sativa L. Protects Intestinal Barrier From In Vitro Inflammation and Oxidative Stress

  2021cites this paper
• Endocannabinoid system and its modulation of brain, gut, joint and skin inflammation

  2021cites this paper
• Cannabidiol selectively modulates interleukin (IL)-1β and IL-6 production in toll-like receptor activated human peripheral blood monocytes.

  2021cites this paper
• Effects of cannabis ingestion on endometriosis-associated pelvic pain and related symptoms

  2021influential citation
• Cannabis and Inflammatory Bowel Disease: All Smoke and Mirrors?

  2021cites this paper
• Cannabidiol and Sports Performance: a Narrative Review of Relevant Evidence and Recommendations for Future Research

  2020influential citation
• Cannabinoids and Opioids in the Treatment of Inflammatory Bowel Diseases

  2020cites this paper
• Antioxidant and Neuroprotective Effects Induced by Cannabidiol and Cannabigerol in Rat CTX-TNA2 Astrocytes and Isolated Cortexes

  2020cites this paper
• An overview of cannabis based treatment in Crohn’s disease

  2020cites this paper
• The potential role of interventions impacting on gut-microbiota in epilepsy

  2020cites this paper
• Role of Cannabis and Its Derivatives in Gastrointestinal and Hepatic Disease.

  2020cites this paper
• Cannabis in inflammatory bowel disease: a narrative summary

  2020cites this paper
• A randomized, double-blind, placebo-controlled study of daily cannabidiol for the treatment of canine osteoarthritis pain.

  2020cites this paper
• Cannabidiol and Other Non-Psychoactive Cannabinoids for Prevention and Treatment of Gastrointestinal Disorders: Useful Nutraceuticals?

  2020cites this paper
• Cannabidiol Oil-Associated Microscopic Colitis

  2020cites this paper
• Fish Oil, Cannabidiol and the Gut Microbiota: An Investigation in a Murine Model of Colitis

  2020cites this paper
• Efficacy of combined therapy with fish oil and phytocannabinoids in murine intestinal inflammation

  2020influential citation
• Natural cannabinoids suppress the cytokine storm in sepsis-like in vitro model

  2020cites this paper
• Immune Responses Regulated by Cannabidiol

  2020cites this paper
• Beyond THC and Endocannabinoids.

  2020cites this paper
• Cannabidiol As A Novel Therapeutic Strategy For Oral Inflammatory Diseases: A Review Of Current Knowledge And Future Perspectives.

  2020cites this paper
• Cannabidiol Promotes Endothelial Cell Survival by Heme Oxygenase-1-Mediated Autophagy

  2020cites this paper
• A Systematic Review With Meta-Analysis of the Efficacy of Cannabis and Cannabinoids for Inflammatory Bowel Disease

  2020cites this paper
• Interventions of natural and synthetic agents in inflammatory bowel disease, modulation of nitric oxide pathways

  2020cites this paper
• Global Trends in Cannabis and Cannabidiol Research from 1940 to 2019.

  2020cites this paper
• Effects of Cannabidiol Supplementation on Skeletal Muscle Regeneration after Intensive Resistance Training

  2020cites this paper
• A Case Report of Cannabidiol Treatment of a Crohn's Disease Patient With Anxiety Disorder.

  2019cites this paper
• Cannabinoids and the Microbiota-Gut-Brain-Axis: Emerging Effects of Cannabidiol and Potential Applications to Alcohol Use Disorders.

  2019cites this paper
• The protective mechanism of cannabidiol in cardiac injury: A systematic review of non-clinical studies.

  2019cites this paper
• Members of the endocannabinoid system are distinctly regulated in inflammatory bowel disease and colorectal cancer

  2019cites this paper
• The non-euphoric phytocannabinoid cannabidivarin counteracts intestinal inflammation in mice and cytokine expression in biopsies from UC pediatric patients.

  2019cites this paper
• Cannabinoids and inflammation: Implications for People Living with HIV.

  2019cites this paper
• Effects of O‐1602 and CBD on TNBS‐induced colonic disturbances

  2019cites this paper
• Opportunities for cannabis in supportive care in cancer

  2019cites this paper
• Herbal medicinal products for inflammatory bowel disease: A focus on those assessed in double‐blind randomised controlled trials

  2019cites this paper
• Cannabinoids in Autoimmune and Rheumatic Diseases

  2019cites this paper
• Imaging Biomarkers of the Neuroimmune System among Substance Use Disorders: A Systematic Review

  2019cites this paper
• Low doses of widely consumed cannabinoids (cannabidiol and cannabidivarin) cause DNA damage and chromosomal aberrations in human-derived cells

  2018cites this paper
• The Use of Cannabinoids in Colitis: A Systematic Review and Meta-Analysis.

  2018cites this paper
• A Randomized, Double-blind, Placebo-controlled, Parallel-group, Pilot Study of Cannabidiol-rich Botanical Extract in the Symptomatic Treatment of Ulcerative Colitis.

  2018cites this paper